Cardiac biomarkers.
作者信息
Mair Johannes, Jaffe Allan, Apple Fred, Lindahl Bertil
机构信息
Department of Internal Medicine III (Cardiology and Angiology), Innsbruck Medical University, 6020 Innsbruck, Austria.
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Medical School, Rochester, MN 55905, USA.
出版信息
Dis Markers. 2015;2015:370569. doi: 10.1155/2015/370569. Epub 2015 Apr 19.
Abstract
摘要
相似文献
1
Cardiac biomarkers.心脏生物标志物
Dis Markers. 2015;2015:370569. doi: 10.1155/2015/370569. Epub 2015 Apr 19.
2
Cardiac biomarkers - A short biography.心脏生物标志物——简史
Clin Biochem. 2015 Mar;48(4-5):197-200. doi: 10.1016/j.clinbiochem.2014.11.014. Epub 2014 Nov 22.
3
Interferon regulatory factors: New targets for intervention of cardiovascular diseases.干扰素调节因子：心血管疾病干预的新靶点。
Int J Cardiol. 2015 Feb 15;181:355-6. doi: 10.1016/j.ijcard.2014.12.084. Epub 2014 Dec 23.
4
Biomarkers for prediction of cardiovascular events.用于预测心血管事件的生物标志物。
JAMA. 2009 Nov 18;302(19):2089-90; author reply 2090. doi: 10.1001/jama.2009.1637.
5
Biomarkers for prediction of cardiovascular events.用于预测心血管事件的生物标志物。
JAMA. 2009 Nov 18;302(19):2089; author reply 2090. doi: 10.1001/jama.2009.1636.
6
Biomarkers in cardiovascular medicine: the shame of publication bias.心血管医学中的生物标志物：发表偏倚之耻。
JAMA Intern Med. 2013 Apr 22;173(8):671-2. doi: 10.1001/jamainternmed.2013.4074.
7
Ischemia modified albumin in cardiovascular disease.心血管疾病中的缺血修饰白蛋白
Am J Emerg Med. 2016 Aug;34(8):1699. doi: 10.1016/j.ajem.2016.05.030. Epub 2016 May 14.
8
Use of cardiac biomarkers in end-stage renal disease.心脏生物标志物在终末期肾病中的应用。
J Am Soc Nephrol. 2008 Sep;19(9):1643-52. doi: 10.1681/ASN.2008010012. Epub 2008 Mar 5.
9
Review on cardiovascular risk prediction.心血管风险预测综述
Cardiovasc Ther. 2015 Apr;33(2):62-70. doi: 10.1111/1755-5922.12110.
10
Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.血液透析患者的心脏生物标志物：氨基末端B型利钠肽原和心肌肌钙蛋白T的预后价值
Nephron Clin Pract. 2007;107(3):c77-81. doi: 10.1159/000108647. Epub 2007 Sep 21.
引用本文的文献
1
Cardiac Biomarkers Aid in Differentiation of Kawasaki Disease from Multisystem Inflammatory Syndrome in Children Associated with COVID-19.心脏生物标志物有助于区分川崎病与儿童新冠病毒相关多系统炎症综合征。
Pediatr Cardiol. 2025 Jan;46(1):116-126. doi: 10.1007/s00246-023-03338-z. Epub 2023 Dec 29.
2
Blood-Based Markers for Skeletal and Cardiac Muscle Function in Eventing Horses before and after Cross-Country Rides and How They Are Influenced by Plasma Volume Shift.越野骑行前后三项赛马匹骨骼和心肌功能的血液标志物及其如何受血浆容量变化的影响
Animals (Basel). 2023 Oct 5;13(19):3110. doi: 10.3390/ani13193110.
3
High-throughput immunosensor chip coupled with a fluorescent DNA dendrimer for ultrasensitive detection of cardiac troponin T.高通量免疫传感器芯片与荧光DNA树枝状大分子结合用于超灵敏检测心肌肌钙蛋白T。
RSC Adv. 2021 Aug 13;11(44):27523-27529. doi: 10.1039/d1ra03420k. eCollection 2021 Aug 9.
4
Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis.COVID-19 患儿中多系统炎症综合征（MIS-C）的心脏标志物：一项荟萃分析。
Am J Emerg Med. 2021 Nov;49:62-70. doi: 10.1016/j.ajem.2021.05.044. Epub 2021 May 18.
5
Associations between estimated glomerular filtration rate and cardiac biomarkers.估算肾小球滤过率与心脏生物标志物的相关性。
J Clin Lab Anal. 2020 Aug;34(8):e23336. doi: 10.1002/jcla.23336. Epub 2020 Apr 16.
6
Evaluation of cardiac troponin I in serum and myocardium of rabbits with experimentally induced polymicrobial sepsis.评价实验性多微生物脓毒症兔血清和心肌中心肌钙蛋白 I。
Exp Anim. 2020 Jan 29;69(1):54-61. doi: 10.1538/expanim.19-0046. Epub 2019 Aug 29.
7
Point-of-Care Compatibility of Ultra-Sensitive Detection Techniques for the Cardiac Biomarker Troponin I-Challenges and Potential Value.即时检测超敏检测技术在心肌标志物肌钙蛋白 I 中的应用——挑战与潜在价值。
Biosensors (Basel). 2018 Nov 21;8(4):114. doi: 10.3390/bios8040114.
本文引用的文献
1
Genes and cardiovascular risk.基因与心血管风险。
Eur Heart J. 2013 Apr;34(13):949-50. doi: 10.1093/eurheartj/ehs439. Epub 2012 Dec 19.
2
Third universal definition of myocardial infarction.心肌梗死的第三次全球定义。
Eur Heart J. 2012 Oct;33(20):2551-67. doi: 10.1093/eurheartj/ehs184. Epub 2012 Aug 24.
3
How to use high-sensitivity cardiac troponins in acute cardiac care.如何在急性心脏护理中使用高敏心肌肌钙蛋白
Eur Heart J. 2012 Sep;33(18):2252-7. doi: 10.1093/eurheartj/ehs154. Epub 2012 Jun 21.
4
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.急性心脏护理中利钠肽使用的建议：欧洲心脏病学会急性心脏护理工作组心脏病生物标志物研究组的立场声明
Eur Heart J. 2012 Aug;33(16):2001-6. doi: 10.1093/eurheartj/ehq509. Epub 2011 Feb 2.
5
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.用于预测社区中心血管事件发生的新型和传统生物标志物。
JAMA. 2009 Jul 1;302(1):49-57. doi: 10.1001/jama.2009.943.
6
Emerging role of microRNAs in cardiovascular biology.微小RNA在心血管生物学中的新作用。
Circ Res. 2007 Dec 7;101(12):1225-36. doi: 10.1161/CIRCRESAHA.107.163147.
7
Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence.心肌梗死候选多态性的遗传效应与偏倚：病例研究及大规模证据综述
Am J Epidemiol. 2007 May 1;165(9):973-84. doi: 10.1093/aje/kwk085. Epub 2007 Feb 10.
8
RISK FACTORS IN CORONARY HEART DISEASE. AN EVALUATION OF SEVERAL SERUM LIPIDS AS PREDICTORS OF CORONARY HEART DISEASE; THE FRAMINGHAM STUDY.冠心病的危险因素。评估几种血清脂质作为冠心病预测指标的研究；弗明汉姆研究。
Ann Intern Med. 1964 Nov;61:888-99. doi: 10.7326/0003-4819-61-5-888.
9
Reduction of alpha-ketobutyrate by human serum.人血清对α-酮丁酸的还原作用。
Nature. 1960 Dec 24;188:1110-1. doi: 10.1038/1881110a0.
10
Lactic dehydrogenase activity in blood.血液中的乳酸脱氢酶活性。
Proc Soc Exp Biol Med. 1955 Oct;90(1):210-3. doi: 10.3181/00379727-90-21985.
Zotero 插件